Cargando…
Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations
Antiphospholipid syndrome (APS) is a multisystem autoimmune disorder that can affect children and adults alike, with a similar spectrum of thrombotic events, predominately deep vein thrombosis and stroke. It is characterized by recurrent arterial or venous thrombosis and recurrent fetal loss with th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780955/ https://www.ncbi.nlm.nih.gov/pubmed/35103179 http://dx.doi.org/10.7759/cureus.20603 |
_version_ | 1784637969907318784 |
---|---|
author | Al-Dohayan, Nora D Al-Batniji, Fatma Alotaibi, Hammam A Elbaage, Abdulaziz T |
author_facet | Al-Dohayan, Nora D Al-Batniji, Fatma Alotaibi, Hammam A Elbaage, Abdulaziz T |
author_sort | Al-Dohayan, Nora D |
collection | PubMed |
description | Antiphospholipid syndrome (APS) is a multisystem autoimmune disorder that can affect children and adults alike, with a similar spectrum of thrombotic events, predominately deep vein thrombosis and stroke. It is characterized by recurrent arterial or venous thrombosis and recurrent fetal loss with the presence of antiphospholipid antibodies (aPL) like antibodies to beta-2-glycoprotein I (B-2-GPI) and anticardiolipin (aCL). The disease could be classified into primary APS in the absence of an underlying disease or secondary APS occurring secondary to autoimmune diseases, infections, malignancies, and sometimes medication use. In the absence of clinical manifestations of APS, transient non-thrombogenic antiphospholipid antibodies are seen more commonly in children, predominantly after childhood infections. Cases with clinical manifestations of APS associated with different types of infections have been reported in the literature to keep track of potential triggering causes and take measures to prevent or treat the disease manifestations. This case documents the case of hepatitis-A as a triggering viral infection, causing secondary APS in a child. |
format | Online Article Text |
id | pubmed-8780955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-87809552022-01-30 Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations Al-Dohayan, Nora D Al-Batniji, Fatma Alotaibi, Hammam A Elbaage, Abdulaziz T Cureus Ophthalmology Antiphospholipid syndrome (APS) is a multisystem autoimmune disorder that can affect children and adults alike, with a similar spectrum of thrombotic events, predominately deep vein thrombosis and stroke. It is characterized by recurrent arterial or venous thrombosis and recurrent fetal loss with the presence of antiphospholipid antibodies (aPL) like antibodies to beta-2-glycoprotein I (B-2-GPI) and anticardiolipin (aCL). The disease could be classified into primary APS in the absence of an underlying disease or secondary APS occurring secondary to autoimmune diseases, infections, malignancies, and sometimes medication use. In the absence of clinical manifestations of APS, transient non-thrombogenic antiphospholipid antibodies are seen more commonly in children, predominantly after childhood infections. Cases with clinical manifestations of APS associated with different types of infections have been reported in the literature to keep track of potential triggering causes and take measures to prevent or treat the disease manifestations. This case documents the case of hepatitis-A as a triggering viral infection, causing secondary APS in a child. Cureus 2021-12-22 /pmc/articles/PMC8780955/ /pubmed/35103179 http://dx.doi.org/10.7759/cureus.20603 Text en Copyright © 2021, Al-Dohayan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Ophthalmology Al-Dohayan, Nora D Al-Batniji, Fatma Alotaibi, Hammam A Elbaage, Abdulaziz T Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations |
title | Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations |
title_full | Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations |
title_fullStr | Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations |
title_full_unstemmed | Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations |
title_short | Hepatitis-A Infection-Induced Secondary Antiphospholipid Syndrome With Neuro-ophthalmological Manifestations |
title_sort | hepatitis-a infection-induced secondary antiphospholipid syndrome with neuro-ophthalmological manifestations |
topic | Ophthalmology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780955/ https://www.ncbi.nlm.nih.gov/pubmed/35103179 http://dx.doi.org/10.7759/cureus.20603 |
work_keys_str_mv | AT aldohayannorad hepatitisainfectioninducedsecondaryantiphospholipidsyndromewithneuroophthalmologicalmanifestations AT albatnijifatma hepatitisainfectioninducedsecondaryantiphospholipidsyndromewithneuroophthalmologicalmanifestations AT alotaibihammama hepatitisainfectioninducedsecondaryantiphospholipidsyndromewithneuroophthalmologicalmanifestations AT elbaageabdulazizt hepatitisainfectioninducedsecondaryantiphospholipidsyndromewithneuroophthalmologicalmanifestations |